 |
市場調查報告書
商品編碼
2148312
連續生物程序市場：按產品、工藝、營運規模、應用、最終用戶和地區分類Continuous Bioprocessing Market, By Product, By Process, By Scale of Operation, By Application, By End User, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，連續生物製程市場規模將達到 5.124 億美元，到 2033 年將達到 19.913 億美元。預計從 2026 年到 2033 年，該市場將以 21.4% 的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 5.124億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 21.40% | 2033年市場規模預測： | 1,991,300,000 美元 |
全球連續生物製程製程市場已從傳統的生物製藥間歇式生產發展為連續、整合、高效的生物製藥生產。該市場以灌註生物反應器、連續層析法和線上監測等技術的應用為特徵，用於生產單株抗體、疫苗、重組蛋白以及細胞和基因療法等生技藥品，同時提高製程一致性、產品品質、生產空間利用率和營運效率。
生物製藥需求的不斷成長，以及生物製藥公司對提高生產經濟效益和縮短產品上市時間的重視，也推動了這項技術的市場應用。此外，有關品質源自於設計 (QbD) 和流程分析技術 (PAT) 的監管舉措，以及自動化和數位整合技術的進步，也加速了向連續生產的轉型，而連續生產正是下一代生物製藥生產的關鍵要素。
市場動態
全球連續生物製程市場的發展主要受生物製藥產品（如單株抗體、生物相似藥、疫苗以及細胞和基因療法）需求成長的驅動。這是因為製造商尋求提高生產效率、降低生產成本、最大限度地減少廠房面積並增強製程一致性。監管支援以及製程分析技術 (PAT)、人工智慧、機器學習和即時放行檢測的整合，進一步推動了生物製藥製造商對連續生物製程的採用。
然而，生物相似藥市場面臨許多限制因素，包括從批次生產模式轉型所需的大量資本投入、製程驗證的複雜性、監管的不確定性以及熟練專業人員的短缺。儘管如此，生物相似藥領域仍蘊藏著巨大的機遇，尤其是在亞太和拉丁美洲地區，個人化醫療、模組化生產以及技術提供者、合約研發生產機構（CDMO）和生物製藥公司之間的策略合作，都為該領域帶來了可觀的商業機會。
本次調查的主要特點
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數介紹了全球連續生物製程市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 這份「全球連續生物製程市場」報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用全球連續生物製程市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監管與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 市場機遇
- 產業趨勢
第4章 全球連續生物製程市場：依產品分類，2021-2033年
- 連續生物反應器
- 連續層析法系統
- 連續過濾系統
- 連續細胞培養系統
- 連續培養基和緩衝液製備系統
- 連續病毒去活化系統
- 連續下游處理系統
- 其他
第5章 全球連續生物程序市場：依工藝分類，2021-2033年
- 上游工程
- 下游加工
第6章 全球連續生物製程市場：依企業規模分類，2021-2033年
- 小規模
- 中號
- 大規模
第7章 全球連續生物製程市場：依應用領域分類，2021-2033年
- 單株抗體
- 重組蛋白
- 疫苗
- 細胞和基因治療
- 血液和血漿製品
- 其他
第8章 全球連續生物程序市場：依最終用戶分類，2021-2033年
- 生物製藥公司
- 契約製造組織 (CMO) / 合約開發與生產組織 (CDMO)
- 學術研究機構
- 其他
第9章 全球連續生物製程市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Danaher Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Repligen Corporation
- Eppendorf SE
- Getinge AB
- 3M Company
- Lonza Group Ltd.
- Asahi Kasei Corporation
第11章 分析師建議
- 機會分析
- 分析師意見
- Coherent Opportunity Map
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI10122
Continuous Bioprocessing Market is estimated to be valued at USD 512.4 Mn in 2026 and is expected to reach USD 1,991.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 21.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 512.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 21.40% | 2033 Value Projection: | USD 1,991.3 Mn |
The global continuous bioprocessing market is an evolution of the traditional batch manufacturing of biopharmaceuticals to the continuous, integrated and efficient production of biopharmaceuticals. The global continuous bioprocessing market is characterized by the use of technologies such as perfusion bioreactors, continuous chromatography and inline monitoring to manufacture biologicals such as monoclonal antibodies, vaccines, recombinant proteins and cell and gene therapies, while enhancing the process consistency, product quality, manufacturing footprint and operational efficiency.
The increasing demand for biologics and the biopharmaceutical companies' focus on improving the economics of production and shortening the time-to-market are also driving the market adoption. Quality by Design (QbD) and Process Analytical Technology (PAT) regulatory initiatives, along with advances in automation and digital integration are also helping to accelerate the move toward continuous manufacturing as a significant part of next generation biopharmaceutical production.
Market Dynamics
The global continuous bioprocessing market is driven by the increasing demand for biologics such as monoclonal antibodies, biosimilars, vaccines and cell and gene therapies as manufacturers require higher productivity, lower cost of goods, smaller facility footprints and better process consistency. Regulatory support along with integration of Process Analytical Technology (PAT), artificial intelligence, machine learning and real-time release testing is further fueling adoption across biopharmaceutical manufacturers.
However, a number of constraints are present in the market, such as high capital requirements for migrating from batch-based infrastructure, complexity of process validation, regulatory uncertainty, and limited pool of skilled professionals. Nevertheless, significant opportunities exist in biosimilars, especially in Asia Pacific and Latin America, and presents considerable opportunities, as does individualized medicine, modular manufacturing and strategic alliances between technology providers, CDMOs and biopharmaceutical companies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global continuous bioprocessing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Danaher Corporation, Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, Repligen Corporation, Eppendorf SE, Getinge AB, 3M Company, Lonza Group Ltd., and Asahi Kasei Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global continuous bioprocessing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous bioprocessing market
Market Segmentation
- Product Insights (Revenue, USD Mn, 2021 - 2033)
- Continuous Bioreactors
- Continuous Chromatography Systems
- Continuous Filtration Systems
- Continuous Cell Culture Systems
- Continuous Media and Buffer Preparation Systems
- Continuous Virus Inactivation Systems
- Continuous Downstream Processing Systems
- Others
- Process Insights (Revenue, USD Mn, 2021 - 2033)
- Upstream Processing
- Downstream Processing
- Scale of Operation Insights (Revenue, USD Mn, 2021 - 2033)
- Small-Scale
- Medium-Scale
- Large-Scale
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Cell and Gene Therapies
- Blood and Plasma Products
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutes
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Danaher Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Repligen Corporation
- Eppendorf SE
- Getinge AB
- 3M Company
- Lonza Group Ltd.
- Asahi Kasei Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Continuous Bioprocessing Market, By Product
- Global Continuous Bioprocessing Market, By Process
- Global Continuous Bioprocessing Market, By Scale of Operation
- Global Continuous Bioprocessing Market, By Application
- Global Continuous Bioprocessing Market, By End User
- Global Continuous Bioprocessing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Continuous Bioprocessing Market, By Product, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Continuous Bioreactors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Chromatography Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Filtration Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Cell Culture Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Media and Buffer Preparation Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Virus Inactivation Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Continuous Downstream Processing Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Continuous Bioprocessing Market, By Process, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Upstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Downstream Processing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Continuous Bioprocessing Market, By Scale of Operation, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medium-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large-Scale
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Continuous Bioprocessing Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cell and Gene Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Blood and Plasma Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Continuous Bioprocessing Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Manufacturing Organizations (CMOs) / Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Continuous Bioprocessing Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Process, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operation, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Repligen Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eppendorf SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
